COVID-19 ARDS in two patients with left ventricular assist device
- 1 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Artificial Organs
- Vol. 25 (2), 148-154
- https://doi.org/10.1007/s10047-021-01288-y
Abstract
Coronavirus disease 2019 affected millions of people and caused pneumonia, acute respiratory distress syndrome and increased mortality worldwide. Data from multicenter studies showed that concomitant chronic diseases are associated with severe coronavirus disease. Patients with left ventricular assist device (LVAD) support may also be vulnerable to the disease. Some symptoms of COVID-19 infection like dyspnea and fatigue can overlap with heart failure or LVAD dysfunction. Careful evaluation should be made to diagnose and treat these patients. In these two cases with COVID-19, here we presented the first two patients supported with LVAD in Turkey.Keywords
This publication has 14 references indexed in Scilit:
- Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysisThrombosis Research, 2020
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)JAMA Cardiology, 2020
- An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular DiseasesJAMA Cardiology, 2020
- Predisposition or Protection?JACC: Case Reports, 2020
- Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device SupportJournal of Cardiac Failure, 2020
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 2020
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the pastJournal of Clinical Virology, 2020
- The Imperfect Cytokine StormJACC: Case Reports, 2020
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInternational Journal of Antimicrobial Agents, 2020
- [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].2020